279 related articles for article (PubMed ID: 12494093)
41. Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus.
Shahian DM; Labib SB; Schneebaum AB
J Card Surg; 1995 Mar; 10(2):133-9. PubMed ID: 7772877
[TBL] [Abstract][Full Text] [Related]
42. Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report.
Le Ho Y; Ahmad Zaidi NA; Salleh A; Abdul Kareem BA
J Cardiothorac Surg; 2021 Apr; 16(1):92. PubMed ID: 33865405
[TBL] [Abstract][Full Text] [Related]
43. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
[TBL] [Abstract][Full Text] [Related]
45. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
[TBL] [Abstract][Full Text] [Related]
46. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
[TBL] [Abstract][Full Text] [Related]
47. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases.
Chalvon NB; Costedoat-Chalumeau N; Pennaforte JL; Servettaz A; Boulagnon Rombi C; Gavand PE; Lekieffre M; Le Guern V; Morel N; Cohen Aubart F; Haroche J; Mathian A; Collet JP; Piette JC; Amoura Z; Orquevaux P
Rheumatology (Oxford); 2023 Feb; 62(2):707-715. PubMed ID: 35686908
[TBL] [Abstract][Full Text] [Related]
48. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
49. [Systemic lupus erythematosus: valvular regurgitation and its relation to anticardiolipin antibodies].
Díaz RA; Athanassopoulos G; Nihoyannopoulos P
Rev Med Chil; 1993 Feb; 121(2):156-61. PubMed ID: 8303111
[TBL] [Abstract][Full Text] [Related]
50. A Tale of Two Valves: Bioprosthetic Aortic Valve Obstruction in Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.
Dietrich M; Bois M; Ferrufino R; Cobey F; Mankad R
J Cardiothorac Vasc Anesth; 2020 Dec; 34(12):3462-3466. PubMed ID: 32800619
[TBL] [Abstract][Full Text] [Related]
51. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus.
Khamashta MA; Cervera R; Asherson RA; Font J; Gil A; Coltart DJ; Vázquez JJ; Paré C; Ingelmo M; Oliver J
Lancet; 1990 Jun; 335(8705):1541-4. PubMed ID: 1972484
[TBL] [Abstract][Full Text] [Related]
52. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
53. Valvular heart disease and systemic lupus erythematosus: therapeutic implications.
Fluture A; Chaudhari S; Frishman WH
Heart Dis; 2003; 5(5):349-53. PubMed ID: 14503933
[TBL] [Abstract][Full Text] [Related]
54. Cerebral changes in SLE with or without antiphospholipid syndrome. a case-control MRI study.
Valdés-Ferrer SI; Vega F; Cantú-Brito C; Ceballos-Ceballos J; Estañol B; García-Ramos G; Cabral AR
J Neuroimaging; 2008 Jan; 18(1):62-5. PubMed ID: 18190498
[TBL] [Abstract][Full Text] [Related]
55. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome.
Cervera R; Khamashta MA; Font J; Reyes PA; Vianna JL; López-Soto A; Amigo MC; Asherson RA; Azqueta M; Paré C
Lupus; 1991 Nov; 1(1):43-7. PubMed ID: 1845363
[TBL] [Abstract][Full Text] [Related]
56. Valvulitis requiring triple valve surgery as an initial presentation of systemic lupus erythematosus.
Einav E; Gitig A; Marinescu LM; Tanaka KE; Spevack DM
J Am Soc Echocardiogr; 2007 Nov; 20(11):1315.e1-3. PubMed ID: 17600680
[TBL] [Abstract][Full Text] [Related]
57. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease.
Amital H; Langevitz P; Levy Y; Afek A; Goldberg I; Pras M; Livneh A; Shoenfeld Y
Clin Exp Rheumatol; 1999; 17(1):99-102. PubMed ID: 10084041
[TBL] [Abstract][Full Text] [Related]
58. Cardiac involvement in connective tissue diseases and primary antiphospholipid syndrome: echocardiographic assessment and correlation with antiphospholipid antibodies.
Gabrielli F; Alcini E; Prima MA; Lucifero A; Masala C
Acta Cardiol; 1996; 51(5):425-39. PubMed ID: 8922048
[TBL] [Abstract][Full Text] [Related]
59. Valvular heart disease and systemic lupus erythematosus.
McCarthy GM; McCarty DJ
N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132593
[No Abstract] [Full Text] [Related]
60. Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus.
Spadaro A; Riccieri V; Terracina S; Rinaldi T; Taccari E; Zoppini A
Lupus; 2000; 9(1):56-60. PubMed ID: 10713647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
